Research Progress on Clinical Trials of Antitumor Drugs
10.3971/j.issn.1000-8578.2022.21.0873
- VernacularTitle:抗肿瘤药物临床试验的研究进展
- Author:
Baihong ZHANG
1
;
Hongyun YUE
Author Information
1. Department of Oncology, 940th Hospital of Joint Logistics Support Force of People's Liberation Army, Lanzhou 730050, China
- Publication Type:Research Article
- Keywords:
Cancer;
Clinical trials;
Digital medicine;
Virtual care
- From:
Cancer Research on Prevention and Treatment
2022;49(2):163-166
- CountryChina
- Language:Chinese
-
Abstract:
Conventional clinical trials of antitumor drugs are conducted at clinical sites. In contrast, without clinical sites or site-less, digital clinical trials can be performed online. Virtual clinical trials analyze the therapeutic response of virtual patients to digital drugs using artificial intelligence and may reduce the costs of trials. Precision oncology trials based on biomarkers can invite more people to join clinical trials and guide the optimal choice of therapeutics for cancer patients. Oncology clinical trials will enter the era of digital, virtual and precision medicine.
